Cite

HARVARD Citation

    Tai, M. et al. (2019). Real-world treatment patterns of PCSK9 inhibitors among patients with dyslipidemia in Germany, Spain, and the United Kingdom. Current medical research and opinion. pp. 829-835. [Online]. 
  
Back to record